Genomic Test Helps Decide Which DCIS Needs Radiation

The Oncotype DX Breast DCIS Score test is used to help people and their doctors make decisions about whether radiation after lumpectomy surgery to remove DCIS would offer more benefits than risks. At the 2023 San Antonio Breast Cancer Symposium, Dr. Seema Khan presented results from the E4112 study, evaluating the ability of the Oncotype DX Breast DCIS Score to accurately predict which women would benefit from radiation after DCIS surgery and which women could safely skip radiation. Listen to the podcast to hear Dr. Khan explain: the design of the study, including why a prospective study is important the results how the results fit into the current context of DCIS care